Live Breaking News & Updates on தேசிய பயோடெக் குழு நிறுவனம்

Stay updated with breaking news from தேசிய பயோடெக் குழு நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Over 43 million doses of Sinopharm's Covid-19 vaccines 'used globally'


Over 43 million doses of Sinopharm s Covid-19 vaccines ’used globally’
By Reuters
Share
BEIJING - More than 43 million Covid-19 vaccine doses from China s state-backed China National Pharmaceutical Group (Sinopharm) have been used, including over 34 million administered in the country and the rest overseas, official media said on Sunday.
China National Biotec Group Company (CNBG), a Sinopharm unit, has two Covid-19 vaccines. One of them is developed by its Beijing unit and has been approved for general public use in China and emergency use in several countries including Iraq, Pakistan and Morocco.
The other vaccine, developed by CNBG s Wuhan unit, has also obtained China s green light for emergency use targeting mainly select groups of higher virus exposure risk. ....

Equatorial Guinea , Cansino Biologics , China Central Television , Sinovac Biotech , China National Biotec Group Company , China National Pharmaceutical Group Sinopharm , China National Pharmaceutical Group , National Biotec Group Company , Central Television , Congo Republic , பூமத்திய ரேகை கினியா , கேன்சினோ உயிரியல் , சீனா மைய தொலைக்காட்சி , சீனா தேசிய பயோடெக் குழு நிறுவனம் , சீனா தேசிய மருந்து குழு , தேசிய பயோடெக் குழு நிறுவனம் , மைய தொலைக்காட்சி , காங்கோ குடியரசு ,

Over 43 million doses of Sinopharm's COVID-19 vaccines used globally: state media


Over 43 million doses of Sinopharm s COVID-19 vaccines used globally: state media
Reuters
22/02/2021
© Reuters/SEBASTIAN CASTANEDA
FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in Lima
(This story corrects last paragraph to read China has promised to donate vaccines to several countries, not they have been delivered)
BEIJING (Reuters) - More than 43 million COVID-19 vaccine doses from China s state-backed China National Pharmaceutical Group (Sinopharm) have been used, including over 34 million administered in the country and the rest overseas, official media said on Sunday.
China National Biotec Group Company (CNBG), a Sinopharm unit, has two COVID-19 vaccines. One of them is developed by its Beijing unit and has been approved for general public use in China and emergency use in several countries including Iraq, Pakistan and Morocco. ....

Equatorial Guinea , Raju Gopalakrishnan , Roxanne Liu , Miyoung Kim , Cansino Biologics , China Central Television , Sinovac Biotech , China National Biotec Group Company , China National Pharmaceutical Group Sinopharm , China National Pharmaceutical Group , National Biotec Group Company , Central Television , Congo Republic , Ryan Woo , பூமத்திய ரேகை கினியா , ராஜு கோபாலகிரிஷ்னன் , ரோக்ஷ்ண்னே லியூ , கேன்சினோ உயிரியல் , சீனா மைய தொலைக்காட்சி , சீனா தேசிய பயோடெக் குழு நிறுவனம் , சீனா தேசிய மருந்து குழு , தேசிய பயோடெக் குழு நிறுவனம் , மைய தொலைக்காட்சி , காங்கோ குடியரசு , ரியான் வூ ,